These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 886456)

  • 1. Interrelation between two anticomplement cobra venom factors isolated from crude Naja naja cobra venom.
    Johnson BJ; Kucich UN
    J Pharm Sci; 1977 Jul; 66(7):947-9. PubMed ID: 886456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of anticomplement factor (cobra venom factor) from the Naja naja atra venom.
    Takahashi H; Hayashi K
    Biochim Biophys Acta; 1982 Feb; 701(1):102-10. PubMed ID: 6173071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complete amino acid sequence of a cardiotoxin from the venom of Naja naja (Cambodian Cobra).
    Fryklund L; Eaker D
    Biochemistry; 1975 Jul; 14(13):2860-5. PubMed ID: 1148180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Major complement inhibiting factors from the venom of the Central Asian cobra Naja naja oxiana].
    Kozlov LV; Shoĭbonov BB; Antonov VK
    Biokhimiia; 1989 Nov; 54(11):1919-26. PubMed ID: 2627558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and properties of a complement inhibitor from Naja haje venom, distinct from known anticomplementary factors in cobra venom.
    von Zabern I; Przyklenk H; Damerau B; Zimmermann B
    Scand J Immunol; 1981 Aug; 14(2):109-20. PubMed ID: 6914809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complement-inhibiting acidic factors from the venom of Central Asian cobra Naja naja oxiana].
    Shobonov BB; Kozlov LV; Antonov VK
    Biokhimiia; 1989 Dec; 54(12):2054-60. PubMed ID: 2633805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
    Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
    Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naja melanoleuca (forest cobra) venom. Purification and some properties of phospholipases A.
    Joubert FJ; Van der Walt SJ
    Biochim Biophys Acta; 1975 Feb; 379(2):317-28. PubMed ID: 1122290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of anticomplementary and adjuvant properties of proteins derived from cobra venom.
    Morrison DC; Louis JA; Weigle WO
    Immunology; 1976 Mar; 30(3):317-23. PubMed ID: 56310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions in red blood cells between fatty acids and either snake venom cardiotoxin or halothane.
    Fletcher JE; Jiang MS; Tripolitis L; Smith LA; Beech J
    Toxicon; 1990; 28(6):657-67. PubMed ID: 2402762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of proteomic profiles of the venoms of two of the 'Big Four' snakes of India, the Indian cobra (Naja naja) and the common krait (Bungarus caeruleus), and analyses of their toxins.
    Choudhury M; McCleary RJR; Kesherwani M; Kini RM; Velmurugan D
    Toxicon; 2017 Sep; 135():33-42. PubMed ID: 28602829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and characterization of a complement-depleting factor from king cobra, Ophiophagus hannah.
    Zeng L; Sun QY; Jin Y; Zhang Y; Lee WH; Zhang Y
    Toxicon; 2012 Sep; 60(3):290-301. PubMed ID: 22561424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical studies on phospholipase A from Formosan cobra (Naja naja atra) venom.
    Lo TB; Chang WC; Chang CS
    Taiwan Yi Xue Hui Za Zhi; 1972 Jun; 71(6):318-22. PubMed ID: 4512906
    [No Abstract]   [Full Text] [Related]  

  • 14. Preparation and characterization of immunoglobulin yolk against the venom of Naja naja atra.
    Liu S; Dong W; Kong T
    Indian J Exp Biol; 2010 Aug; 48(8):778-85. PubMed ID: 21341535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Sendai virus by various snake venom.
    Borkow G; Ovadia M
    Life Sci; 1992; 51(16):1261-7. PubMed ID: 1328790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An improved method for the isolation from Naja naja venom of cobra factor (CoF) free of phospholipase A.
    Pepys MB; Tompkins C; Smith AD
    J Immunol Methods; 1979; 30(2):105-17. PubMed ID: 574149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new low molecular-weight protein effector of human complement from the venom of the Central Asian cobra Naja naja oxiana].
    Kozlov LV; Soliakov LS; Zinchenko AA
    Bioorg Khim; 1984 Mar; 10(3):323-32. PubMed ID: 6567467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The complete covalent structure of a cardiotoxin from the venom of Naja nigricollis (African black-necked spitting cobra).
    Fryklund L; Eaker D
    Biochemistry; 1975 Jul; 14(13):2865-71. PubMed ID: 1148181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation of highly purified ribonuclease from cobra (Naja oxiana) venom].
    Vasilenko SK; Ryte VC
    Biokhimiia; 1975; 40(3):578-83. PubMed ID: 173425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The purification and amino acid sequence of toxin CM-13b from Naja haje annulifera (Egyptian cobra) venom.
    Joubert FJ
    Hoppe Seylers Z Physiol Chem; 1975 Dec; 356(12):1901-8. PubMed ID: 1213685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.